tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immuneering’s Promising Phase 2a Data and Safety Profile Drive Buy Rating
PremiumRatingsImmuneering’s Promising Phase 2a Data and Safety Profile Drive Buy Rating
1M ago
Immuneering Announces Public Offering to Raise $164.1M
Premium
Company Announcements
Immuneering Announces Public Offering to Raise $164.1M
1M ago
Immuneering price target raised to $30 from $21 at Oppenheimer
Premium
The Fly
Immuneering price target raised to $30 from $21 at Oppenheimer
1M ago
Immuneering announces Class A common stock offering, private placement
PremiumThe FlyImmuneering announces Class A common stock offering, private placement
1M ago
Immuneering appoints Schall as Chairman of the Board
Premium
The Fly
Immuneering appoints Schall as Chairman of the Board
2M ago
Immuneering’s Strategic Advances and Positive Outlook Boost Buy Rating and Price Target
Premium
Ratings
Immuneering’s Strategic Advances and Positive Outlook Boost Buy Rating and Price Target
2M ago
Immuneering prices 6.3M shares at $3.95 in private placement
PremiumThe FlyImmuneering prices 6.3M shares at $3.95 in private placement
3M ago
Immuneering Corp. Reports Strong Trial Results and Patent Win
Premium
Company Announcements
Immuneering Corp. Reports Strong Trial Results and Patent Win
3M ago
Immuneering files $300M mixed securities shelf
Premium
The Fly
Immuneering files $300M mixed securities shelf
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100